Edmonton, Canada

Gary David Lopaschuk

USPTO Granted Patents = 22 


 

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 89(Granted Patents)


Location History:

  • Alberta, CA (2003)
  • Edmonton, CA (2004 - 2012)

Company Filing History:


Years Active: 2003-2012

Loading Chart...
Loading Chart...
Loading Chart...
22 patents (USPTO):

Title: The Innovative Contributions of Gary David Lopaschuk

Introduction

Gary David Lopaschuk is a prominent inventor based in Edmonton, Canada, known for his significant contributions to the field of pharmaceutical sciences. With an impressive portfolio of 22 patents, Lopaschuk has focused on innovations that enhance glucose utilization and metabolic modulation, showcasing his commitment to improving healthcare and treatment options.

Latest Patents

Among his most recent patents, Lopaschuk has developed "Compounds that stimulate glucose utilization and methods of use." This invention provides novel compounds that enhance glucose oxidation rates in myocardial cells, an essential process for heart health. It also includes pharmaceutical compositions designed to promote glucose oxidation and methods for treating myocardial ischemia.

Another significant patent is for "Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators." This invention features novel compounds and their prodrugs aimed at treating various metabolic diseases. By inhibiting the enzyme malonyl-coenzyme A decarboxylase, these compounds have potential applications in managing cardiovascular diseases, diabetes, acidosis, cancers, and obesity.

Career Highlights

Gary David Lopaschuk has a distinguished career that includes collaborations with leading institutions and companies. Notably, he has worked with Chugai Seiyaku Kabushiki Kaisha, a major player in pharmaceutical development, and The Governors of the University of Alberta, where he has engaged in research that ignited innovation in the medical field.

Collaborations

Lopaschuk has collaborated with esteemed colleagues such as Jason Roland Dyck and Jie Fei Cheng. These partnerships contribute to the synergy of research and advancement in pharmaceutical sciences, enabling Lopaschuk's inventions to reach their full potential in application and marketability.

Conclusion

In conclusion, Gary David Lopaschuk's work exemplifies the spirit of innovation in the field of pharmaceuticals. His inventions not only add to the scientific community's understanding of glucose metabolism but also pave the way for new treatment methods for chronic diseases. With a robust patent portfolio and continued collaboration with industry leaders, Lopaschuk remains a significant figure in the advancement of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…